Infections and the compromised immune status in the chronically critically ill patient: Prevention strategies

Respiratory Care

Volumn 57, Issue 6, 2012, Pages 979-990

  Cabrera Cancio, Margarita R ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Infection control; Infection rates; Multidrugresistant organisms; Prevalence; Transmissions

Indexed keywords

CEFTAROLINE; COLISTIN; DAPTOMYCIN; DORIPENEM; DOXYCYCLINE; IMIPENEM; LINEZOLID; MEROPENEM; METRONIDAZOLE; MINOCYCLINE; POLYMYXIN B; TELAVANCIN; TIGECYCLINE; VANCOMYCIN;

ACINETOBACTER INFECTION; ANEMIA; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL PNEUMONIA; BACTERIAL TRANSMISSION; BLOODSTREAM INFECTION; BONE MARROW SUPPRESSION; CATHETER INFECTION; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNITY ACQUIRED PNEUMONIA; CRITICAL ILLNESS; DEVICE INFECTION; DIARRHEA; DISEASE SURVEILLANCE; DRUG HALF LIFE; HEADACHE; HOSPITAL CARE; HUMAN; IMMUNE STATUS; IMMUNOCOMPROMISED PATIENT; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; INFUSION RELATED REACTION; KLEBSIELLA PNEUMONIAE; LEUKOPENIA; LONG TERM CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; MYOPATHY; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; OPTIC NERVE DISEASE; PANCYTOPENIA; PATIENT EDUCATION; PERIPHERAL NEUROPATHY; PRURITUS; SIDE EFFECT; SKIN INFECTION; TASTE DISORDER; THROMBOCYTOPENIA; URINARY TRACT INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS; VENTILATOR ASSOCIATED PNEUMONIA; VOMITING; BLADDER CATHETERIZATION; CHRONIC DISEASE; CROSS INFECTION; IMMUNOLOGY; PSEUDOMEMBRANOUS COLITIS; REVIEW;

CHRONIC DISEASE; CRITICAL ILLNESS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; INFECTION CONTROL; PNEUMONIA, VENTILATOR-ASSOCIATED; URINARY CATHETERIZATION;

EID: 84863579028     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01621     Document Type: Article

References (75)

1. Carson SS, Bach PB. The epidemiology and costs of chronic critical illness. Crit Care Clin 2002;18(3):461-476.
2. Kalb TH, Lorin S. Infection in the chronically critically ill: unique risk profile in a newly defined population. Crit Care Clin 2002;18(3): 529-552.
3. Callahan LA, Supinski GS. Sepsis induces diaphragm electron transport chain dysfunction and protein depletion. Am J Respir Crit Care Med 2005;172(2):861-868.
4. Callahan LA, Supinski GS. Downregulation of diaphragm electron transport chain and glycolytic enzyme gene expression in sepsis. J Appl Physiol 2005;99(3):1120-1126.
5. Schuster JM, Nelson PS. Toll receptors: an expanding role in our understanding of human disease. J Leukoc Biol 2000;67(6):767-773.
6. Yang D, Chertov O, Oppenheim JJ. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidins (LL-37). J Leukoc Biol 2001;69(5):691-697.
7. Miller RA. The aging immune system: primer and prospectus. Science 1996;273(5271):70-74.
8. High KP. Nutritional strategies to boost immunity and prevent infection in elderly individuals. Clin Infect Dis 2001;33(11):1892-1900.
9. Musher DM, Luchi MJ, Watson DA, Hamilton R, Baughn RE. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J Infect Dis 1990;161(4):728-735.
10. Khan IH, Catto GR. Long-term complications of dialysis: infection. Kidney Int 1993;(Suppl 41):S143-S148.
11. Cooper Z, Bernacki RE, Divo M. Chronic critical illness: a review for surgeons. Curr Probl Surg 2011;48(1):12-57.
12. Pingleton SK. Nutrition in chronic critical illness. Clin Chest Med 2001;22(1):149-163.
13. Herrero IA, Issa NC, Patel R. Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium. NEngl J Med 2002; 346(11):867-869.
14. Tenover FC, Moellering RC Jr. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin Infect Dis 2007;44(9):1208-1215.
15. Sader HS, Rhomberg PR, Jones RN. Nine-hospital study comparing broth microdilution and Etest methods results for vancomycin and daptomycin against Methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2009;53(7):3162-3165.
16. Kollef MH. Limitations of vancomycin in the management of resistant staphylococcal infections. Clin Infect Dis 2007;45(Suppl 3): S191-S195.
17. Peeters MJ, Sarria JC. Clinical characteristics of linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit. Eur J Clin Microbiol Infect Dis 2002;21:751-754.
18. Wilson P, Andrews JA, Charlesworth R, Walesby R, Singer M, Farrell DJ, Robbines M. Linezolid resistance in clinical isolates of Staphylococcus aureus. J Antimicrob Chemother 2003;51(1):186-188.
19. Saravolatz LD, Stein GE, Johnson LB. Telavancin: a novel lipoglycopeptide. Clin Infect Dis 2009;49(12):1908-1914.
20. Carpenter CF, Chambers HF. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis 2004;38(7):994-1000.
21. Paterson DL, Pasculle AW, McCurry K. Linezolid: the first oxazolidinones antimicrobial. Ann Intern Med 2003;139(10):863-864.
22. Centers for Disease Control and Prevention. Guidance for control of infections with carbapenem-resistant of carbapenamase-producing Enterobacteriaceae in acute car facilities. MMWRMorb Mortal Wkly Rep 2009;58(10):256-260.
23. Endimiani A, Hujer AM, Perez F, Bethel CR, Hujer KM, Kroeger J, et al. Characterization of KPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA. J Antimicrob Chemother 2009;63(3):427-437.
24. Patel G, Huprikar S, Factor S, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29(12):1099-1106.
25. Clinical and Laboratory Standards Institute. 2009 performance standards for antimicrobial susceptibility testing. Nineteenth information supplement (M100-S19); 2009.
26. Stein GE, Craig WA. Tigecycline: a critical analysis. Clin Infect Dis 2006;43(4):518-524.
27. Falagas ME, Kasiakou SK. Colistin: the revival of polymixins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005;40(9):1333-1341. Erratum in: Clin Infect Dis 2006;42(12):1819.
28. Fishbain J, Peleg AY. Treatment of Acinetobacter infections. Clin Infect Dis 2010;51(1):79-84.
29. Lolans K, Rice TW, Munoz-Price S, Quinn JP. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob Agents Chemother 2006;50(9): 2941-2945.
30. Chan JD, Graces JA, Dellit TH. Antimicrobial treatment and clinical outcomes of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia. 2010;25(6):343-348.
31. Bishburg E, Bishburg K. Minocycline-an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii. Int J Antimicrob Agnets 2009;34(5): 395-401. DOI: 10.1016/j.ijantimicag.2009.06.21.
32. Akers KS, Mende K, Yun HC, Hospenthal DR, Beckius ML, Yu X, Murray CK. Tetracycline susceptibility testing and resistance genes in isolates of Acinetobactor baumannii-Acinetobacter calcoaceticus complex from a US military hospital. Antimicro Agents Chemother 2009;53(6):2693-2695.
33. Munoz-Price LS, Stemer A. Four years of surveillance cultures at a long-term acute care hospital. Infect Control Hosp Epidemiol 2010; 31(1):59-63.
34. Tran AK, Lindsay G, Tran AD. A review of Acinetobacter infection in long-term acute care hospital s(LTACHs) (abstract). Chest 2010; 138:520A.
35. Furuno JP, Hebden JN, Standiford HC, Perencevich EN, Miller RR, Moore AC, et al. Prevalence of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii in a long-term care facility. Am J Infect Control 2008;36(7):468-471.
36. Goldstein EJC, Polonsky J, Touzani M, Citron DM.C. difficile infection (CDI) in a long-term acute care facility (LTAC). Anaerobe 2009;15(6):241-243.
37. Calfee D, Jenkins SG. Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients. Infect Control Hosp Epidemiol 2008;29(10):966-968.
38. Gould CV, Rothenberg R, Steinberg JP. Antibiotic resistance in long-term acute care hospitals. Infect Control Hosp Epidemiol 2006; 27(9):920-925.
39. Saeed S, Fakih MG, Riederer K, Shah AR, Khatib R. Interinstitutional and intrainstitutional transmission of a strain of Acinetobacter baumannii detected by molecular analysis: comparison of pulsedfield gel electrophoresis and repetitive sequence-based polymerase chain reaction. Infect Control Hosp Epidemiol 2006;27(9):981-983.
40. Stephens C, Francis SJ, Abell V, DiPersio JR, Wells P. Emergence of resistant Acinetobacter baumannii in critically ill patients within an acute care teaching hospital and a long-term acute care hospital. Am J Infect Control 2007;35(4):212-215.
41. Munoz-Price LS, Hayden MK, Lolans K, Won S, Calvert K, Lin M, et al. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol 2010;31(4):341-347.
42. Ray A, Perez F, Beltramini AM, Jakubowycz M, Dimick P, Jacobs MR, et al. Use of vaporized hydrogen peroxide decontamination during an outbreak of multidrug-resistant Acientobacter baumannii infection at a long-term acute care hospital. Infect Control Hosp Epidemiol 2010;31(12):1236-1241.
43. Smith PW, Bennett G, Bradley S, Drinka P, Lautenbach E, Marx J, et al. SHEA/APIC Guideline: infection prevention and control in the long-term care facility. July 2008. Am J Infect Control 2008;29(9): 785-814.
44. Healthcare Infection Control Practices Advisory Committee; Centers for Disease Control and Prevention. Guidelines for preventing healthcare-associated pneumonia, 2003: recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee. Respir Care 2004;49(8):926-939.
45. O'Grady NP, Alexander M, Burns LA, Dellinger P, Garland J, Heard SO. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2011;39(4 Suppl 1):S1-S34.
46. Gould CV, Umscheid CA, Agarwal RK, Kuntz G, Peques DA, Healthcare Infection Control Practices Advisory Committee. Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol 2010;31(4):319-326.
47. Siegel JD, Rhinehart E, Jackson M, Chiarello L, the Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings, 2006. Am J Infect Control 2007;35(10 Suppl 2):S165-S193.
48. Dudeck MA, Horan TC, Peterson KD, Allen-Bridson K, Morrell GC, Pollock DA, Edwards JR. National Healthcare Safety Network (NHSN) report, data summary for 2009, device-associated module. Am J Infect Control 2011;39(5):349-367.
49. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005;33(10):2184-2193.
50. Walkley AJ, Campbell Reardon C, Sulis CA, Nace N, Joyce-Brady M. Epidemiology of ventilator-associated pneumonia in a long-term acute care hospital. Infect Control Hosp Epidemiol 2009;30(4):319-324.
51. Korah JM, Rumbak MJ, Solomon DA, Cancio MR. Ten year review of decline in nosocomial ventilator-associated pneumonia rates in a long term ventilator care facility post implementation of a pneumonia prevention protocol (abstract). Am J Respir Crit Care Med 2009; 179(Suppl):A1743.
52. Rumbak MJ, Cancio M. Significant reduction in methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia associated with the institution of a prevention protocol. Crit Care Med 1995; 2(7):1200-1203.
53. Munoz-Price LS, Long-term acute care hospitals. Clin Infect Dis 2009;49(3):438-443.
54. Stamilio C, Shuey J, Waters M, Hnatuck P, Tkatch L. Healthcareacquired infection rates in a long-term acute care hospital: a 3-year study (abstract). AmJ Infect Control 2005;33(5)E182. abstract 54574.
55. Munoz-Price LS, Hota B, Stemer A, Weinstein RA. Prevention of bloodstream infections by use of daily chlorhexidine baths for patients at a long-term acute care hospital. Infect Control Hosp Epidemiol 2009;30(11):1031-1035.
56. Wolfenden LL, Anderson G, Veledar E, Srinivasan A. Catheterassociated bloodstream infections in 2 long-term acute care hospitals. Infect Control Hosp Epidemiol 2007;28(1):105-106.
57. Salgado CD, Chinnes L, Paczesny TH, Cantey JR. Increased rate of catheter-related bloodstream infection associated with use of a needleless mechanical valve device at a long-term acute care hospital. Infect Control Hosp Epidemiol 2007;28(6):684-688.
58. Cancio MR, Mayer CA, Patel Y. Prospective in vitro antifungal susceptibilities of fungal blood isolates from long-term acute care vs an acute care hospital. IDSA 47th Annual Meeting, Philadelphia: 2009; M-1535.
59. Caudill T. Reduction in catheter-associated urinary tract infection (CAUTI) using a silver-coated all-silicone Foley catheter versus a silver-impregnated latex Foley catheter in a Southeastern US longterm acute care facility. Am J Infect Control 2005;33(5):e60.
60. Crenich CJ, Drinka PJ. Does the composition of urinary catheters influence clinical outcomes and the results of research studies? Infect Control Hosp Epidemiol 2007;28(1):102-103.
61. Cohen SH, Gerding DN, Johnson D, Kelly CP, Loo VG, McDonald LC. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010;31(5):431-455.
62. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clinical Inf Disease 2003;36(5):580-585.
63. Roup BJ, Roche JC, Pass M. Infection control program disparities between acute and long-term care facilities in Maryland. Am J Infect Control 2006;34(3):122-127.
64. Gould CV. Long-term acute care hospitals: infection control issues. Society for Healthcare Epidemiology of America; 2007. Presentation from CDC.
65. Yokoe DS, Classen D. Improving patient safety through infection control: a new healthcare imperative. Infect Control Hosp Epidemiol 2008;29(Suppl):S3-S11.
66. Yokoe DS, Mermel LA, Anderson DJ, Arias KM, Burstin H, Calfee DP, et al. Compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29(Suppl):S12-S21.
67. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare Infection Control Practices Advisory Committee. 2007 guidelines for isolation precautions: preventing transmission of infectious agents in healthcare settings. http://www.cdc.gov/hicpac/2007IP/2007isolationPrecautions. html. Accessed April 3, 2012.
68. Almario V. A novel approach to the challenges of MDRO management in a long term acute care (LTAC) hospital setting. Am J Infect Control 2010;38(5):e55. presentation 8-060.
69. Grant B. A multi-faceted approach results in sustained improvement in hand hygiene practices at a community hospital (presentation). Association for Professionals in Infection Control and Epidemiology (APIC) 2010. Am J Infect Control 2010;38(5)e55. presentation 8-059.
70. Weber DJ, Rutala WA, Miller MB, Huslage K, Sickbert-Bennett E. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species Am J Infect Control 2010;38(Suppl):S25-S33.
71. Kahnert A, Seiler P, Stein M, Azr B, McDonnell G, Kaufmann SHE. Decontamination with vaporized hydrogen peroxide is effective against Mycobacterium tuberculosis. Lett Appl Microbiol 2005;40(6): 448-452.
72. Nerandzic MM, Cadnum JL, Pultz MJ, Donskey CJ. Evaluation of an automated ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens in hospital rooms. BMC Infect Dis 2010;10:197.
73. Dellie TH, Ocorns RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Disease Society of America and the Society of Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159-77.
74. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171(4):388-416.
75. Liu C, Bayer A, Cosgrove SE. Clinical practice guidelines by the Infectious Disease Society of America for the treatment of methicillin resistant Staphlococcus aureus infections in adults and children. Clin Infect Dis 2011;52(3):e18-e55. Erratum in Clin Infect Dis 2011; 53(3):319.